The emergence of Regenerative Medicine as a driving force in healthcare represents an extraordinary investment opportunity. Proteus is a specialty life sciences fund focused exclusively on Regenerative Medicine. 

Proteus is made up of a talented team of investment and operations veterans with deep domain knowledge, and  the unique business, legal, medical and technology skills necessary to successfully invest in Regenerative Medicine. We have solid track records of building value in portfolios and biotech companies which will enable entrepreneurs that are working diligently to get their technologies from "the lab bench to the bedside".

The Proteus team has aligned itself with key players in academia, industry and government. The Proteus  Advisory Board represents the top leaders within regenerative medicine, thus assimilating the thought leaders of this rapidly evolving field.

Our market research indicates that the RM market has matured, with very large and growing markets with many attractive investment opportunities.

For its investors, the Proteus team has the skills and experience to source deals, evaluate opportunities, build value in portfolio companies and structure lucrative exits.

Proteus Venture Partners is located in Silicon Valley, Boston and Cambridge U.K.